Cite
HARVARD Citation
Shimizu, Y. et al. (2017). When and how disease‐modifying drugs for multiple sclerosis should be changed in daily practice. Clinical & experimental neuroimmunology. 8 (1), pp. 71-80. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shimizu, Y. et al. (2017). When and how disease‐modifying drugs for multiple sclerosis should be changed in daily practice. Clinical & experimental neuroimmunology. 8 (1), pp. 71-80. [Online].